AAAAAA
Results: 1-25/85
Authors:
LANGDON SP
GABRA H
BARTLETT JMS
RABIAZ GJ
HAWKINS RA
TESDALE AL
RITCHIE AA
MILLER WR
SMYTH JF
Citation: Sp. Langdon et al., FUNCTIONALITY OF THE PROGESTERONE-RECEPTOR IN OVARIAN-CANCER AND ITS REGULATION BY ESTROGEN, Clinical cancer research, 4(9), 1998, pp. 2245-2251
PHASE-I STUDY OF INTRAPERITONEAL METALLOPROTEINASE INHIBITOR BB94 IN PATIENTS WITH MALIGNANT ASCITES
Authors:
BEATTIE GJ
SMYTH JF
Citation: Gj. Beattie et Jf. Smyth, PHASE-I STUDY OF INTRAPERITONEAL METALLOPROTEINASE INHIBITOR BB94 IN PATIENTS WITH MALIGNANT ASCITES, Clinical cancer research, 4(8), 1998, pp. 1899-1902
Authors:
SIMPSON BJB
LANGDON SP
RABIASZ GJ
MACLEOD KG
HIRST GL
BARTLETT JMS
CREW AJ
HAWKINS RA
MACINEIRAPEREZ PP
SMYTH JF
MILLER WR
Citation: Bjb. Simpson et al., ESTROGEN REGULATION OF TRANSFORMING GROWTH-FACTOR-ALPHA IN OVARIAN-CANCER, Journal of steroid biochemistry and molecular biology, 64(3-4), 1998, pp. 137-145
Authors:
HERRSTEDT J
AAPRO MS
SMYTH JF
DELFAVERO A
Citation: J. Herrstedt et al., CORTICOSTEROIDS, DOPAMINE ANTAGONISTS AND OTHER DRUGS, Supportive care in cancer, 6(3), 1998, pp. 204-214
Authors:
ROILA F
DELFAVERO A
GRALLA RJ
TONATO M
AAPRO MS
ANDREWS PLR
BALLATORI E
DEMULDER PHM
DICATO MA
DUBOIS A
FEYER PC
GANDARA DR
GRALLA RJ
GRALLA RJ
GROSHEN S
GRUNBERG SM
HERRSTEDT J
HESKETH PJ
JOSS RA
KRIS MG
MARTY MM
MORROW GR
NAYLOR RJ
OLVER IN
SMYTH JF
SPITZER TR
STEWART A
Citation: F. Roila et al., PREVENTION OF CHEMOTHERAPY-INDUCED AND RADIOTHERAPY-INDUCED EMESIS - RESULTS OF THE PERUGIA CONSENSUS CONFERENCE, Annals of oncology, 9(8), 1998, pp. 811-819
Authors:
CUMMINGS J
MACPHERSON JS
SMYTH JF
JODRELL DI
Citation: J. Cummings et al., NOVEL MECHANISM OF DRUG-RESISTANCE TO TOPOISOMERASE-I (TOPO-I) INHIBITORS, Annals of oncology, 9, 1998, pp. 234-234
Authors:
JODRELL DI
BOWMAN A
RYE R
DAWSON L
BYRNE B
GAMBA E
SMYTH JF
Citation: Di. Jodrell et al., A CLINICAL-PHASE-I STUDY OF THE NOVEL ANTHRACENEDIONE ANALOG, BBR-2778, ADMINISTERED INTRAVENOUSLY, 3 WEEKLY, Annals of oncology, 9, 1998, pp. 451-451
Authors:
CLIVE S
JODRELL D
MACLELLAN A
YOUNG A
MILLER M
CUMMINGS J
SMYTH JF
Citation: S. Clive et al., PHASE-I AND PHARMACOKINETIC STUDY OF ANTAGONIST-G - A BROAD-SPECTRUM NEUROPEPTIDE GROWTH-FACTOR ANTAGONIST USING A RAPID DOSE-ESCALATION STRATEGY, Annals of oncology, 9, 1998, pp. 469-469
Authors:
CUMMINGS J
SPANSWICK VJ
RITCHIE AA
SMYTH JF
Citation: J. Cummings et al., PHARMACOLOGICAL DETERMINANTS OF THE ANTITUMOR-ACTIVITY OF MITOMYCIN-C- IMPLICATIONS FOR ENZYME DIRECTED DRUG DEVELOPMENT, Annals of oncology, 9, 1998, pp. 512-512
Authors:
LANGDON SP
RABIASZ GJ
RITCHIE AA
REICHERT U
BUCHAN P
MILLER WR
SMYTH JF
Citation: Sp. Langdon et al., GROWTH-INHIBITORY EFFECTS OF THE SYNTHETIC RETINOID CD437 AGAINST OVARIAN-CARCINOMA MODELS IN-VITRO AND IN-VIVO, Cancer chemotherapy and pharmacology, 42(5), 1998, pp. 429-432
Authors:
SPANSWICK VJ
CUMMINGS J
SMYTH JF
Citation: Vj. Spanswick et al., CURRENT ISSUES IN THE ENZYMOLOGY OF MITOMYCIN-C METABOLIC-ACTIVATION, General pharmacology, 31(4), 1998, pp. 539-544
Authors:
ADAMS M
CALVERT AH
CARMICHAEL J
CLARK PI
COLEMAN RE
EARL HM
GALLAGHER CJ
GANESAN TS
GORE ME
GRAHAM JD
HARPER PG
JAYSON GC
KAYE SB
LEDERMANN JA
OSBORNE RJ
PERREN TJ
POOLE CJ
RADFORD JA
RUSTIN GJS
SLEVIN ML
SMYTH JF
THOMAS H
WILKINSON PM
Citation: M. Adams et al., CHEMOTHERAPY FOR OVARIAN-CANCER - A CONSENSUS STATEMENT ON STANDARD PRACTICE, British Journal of Cancer, 78(11), 1998, pp. 1404-1406
Authors:
MACPHERSON JS
CUMMINGS J
SMYTH JF
JODRELL DI
Citation: Js. Macpherson et al., INVOLVEMENT OF BCL-2 FAMILY MEMBERS IN DRUG-RESISTANCE TO TOPOISOMERASE-I (TOPO-I) INHIBITORS, British Journal of Cancer, 78, 1998, pp. 21-21
Authors:
GILMOUR LMR
MACLEOD KG
MILLER WR
SMYTH JF
LANGDON SP
Citation: Lmr. Gilmour et al., MITOGENIC ACTIONS OF HEREGULIN ISOFORMS AND TGF-ALPHA IN OVARIAN-CANCER MODELS, British Journal of Cancer, 78, 1998, pp. 180-180
Authors:
MULLEN P
MACLEOD K
RABIASZ GJ
SMYTH JF
LANGDON SP
Citation: P. Mullen et al., INTERACTION OF ESTROGEN AND C-ERBB2 SIGNALING PATHWAYS IN OVARIAN-CANCER CELLS, British Journal of Cancer, 78, 1998, pp. 184-184
Authors:
SELLAR GC
RABIASZ GJ
LI L
ALYAHYAHEE S
MILLER EP
TAYLOR KJ
PAIGE A
WATSON JEV
PORTEOUS DJ
SMYTH JF
GABRA H
Citation: Gc. Sellar et al., FUNCTIONAL-ANALYSIS OF NOVEL OVARIAN-CANCER SUPPRESSOR REGIONS ON CHROMOSOME-11, British Journal of Cancer, 78, 1998, pp. 185-185
Authors:
JODRELL DI
BOWMAN A
STEWART M
DUNLOP N
FRENCH R
MACLELLAN A
CUMMINGS J
SMYTH JF
Citation: Di. Jodrell et al., DOSE LIMITING NEUROTOXICITY IN A PHASE-I STUDY OF PENCLOMEDINE (NSC-388720, CRC-88-04), A SYNTHETIC ALPHA-PICOLINE DERIVATIVE, ADMINISTEREDINTRAVENOUSLY, British Journal of Cancer, 77(5), 1998, pp. 808-811
Authors:
CUMMINGS J
SPANSWICK VJ
TOMASZ M
SMYTH JF
Citation: J. Cummings et al., ENZYMOLOGY OF MITOMYCIN-C METABOLIC-ACTIVATION IN TUMOR-TISSUE - IMPLICATIONS FOR ENZYME-DIRECTED BIOREDUCTIVE DRUG DEVELOPMENT, Biochemical pharmacology, 56(4), 1998, pp. 405-414
Authors:
SPANSWICK VJ
CUMMINGS J
RITCHIE AA
SMYTH JF
Citation: Vj. Spanswick et al., PHARMACOLOGICAL DETERMINANTS OF THE ANTITUMOR-ACTIVITY OF MITOMYCIN-C, Biochemical pharmacology, 56(11), 1998, pp. 1497-1503
Authors:
CUMMINGS J
SPANSWICK VJ
GARDINER J
RITCHIE A
SMYTH JF
Citation: J. Cummings et al., PHARMACOLOGICAL AND BIOCHEMICAL DETERMINANTS OF THE ANTITUMOR-ACTIVITY OF THE INDOLOQUINONE EO9, Biochemical pharmacology, 55(3), 1998, pp. 253-260
Authors:
SMYTH JF
Citation: Jf. Smyth, HOW SHOULD WE ASSESS ALTERNATIVE MEDICINE, European journal of cancer, 33, 1997, pp. 1004-1004
Authors:
LANGLEY RE
WOLL PJ
DAVIDSON N
LIBRETTI V
SMYTH JF
SCHIPPER R
CARMICHAEL J
Citation: Re. Langley et al., PHASE-II STUDY OF PACLITAXEL AS FIRST LINE TREATMENT FOR PATIENTS WITH EXTENSIVE-STAGE SMALL-CELL LUNG-CANCER (SCLC), European journal of cancer, 33, 1997, pp. 1040-1040
Authors:
MACPHERSON JS
CUMMINGS J
MEIKLE I
MILLER EP
SMYTH JF
Citation: Js. Macpherson et al., CELL-CYCLE EFFECTS OF THE NOVEL TOPOISOMERASE-I INHIBITOR NU ICRF-505IN A PANEL OF CHINESE-HAMSTER VARY CELL-LINES/, European journal of cancer, 33(2), 1997, pp. 280-283
Authors:
BARTLETT JM
LANGDON SP
SCOTT WN
LOVE SB
MILLER EP
KATSAROS D
SMYTH JF
MILLER WR
Citation: Jm. Bartlett et al., TRANSFORMING-GROWTH-FACTOR-BETA ISOFORM EXPRESSION IN HUMAN OVARIAN-TUMORS, European journal of cancer, 33(14), 1997, pp. 2397-2403
Authors:
SMYTH JF
BOWMAN A
PERREN T
WILKINSON P
PRESCOTT RJ
QUINN KJ
TEDESCHI M
Citation: Jf. Smyth et al., GLUTATHIONE REDUCES THE TOXICITY AND IMPROVES QUALITY-OF-LIFE OF WOMEN DIAGNOSED WITH OVARIAN-CANCER TREATED WITH CISPLATIN - RESULTS OF A DOUBLE-BLIND, RANDOMIZED TRIAL, Annals of oncology, 8(6), 1997, pp. 569-573